Aims To assess whether continuous positive airway pressure (CPAP) therapy reduces major
adverse cardiovascular events (MACE) in patients with moderate-to-severe obstructive …

Obstructive sleep apnea (OSA) commonly occurs in patients with increased cardiovascular
(CV) risk, and continuous positive airway pressure (CPAP) is the preferred therapy for these …

Purpose Continuous positive airway pressure (CPAP) therapy may decrease the risk of
mortality and cardiovascular events in patients with obstructive sleep apnea. However, these …

Background It remains uncertain whether continuous positive airway pressure (CPAP)
therapy would significantly impact hard clinical outcomes in patients with obstructive sleep …

Background and Purpose Obstructive sleep apnea (OSA) has been shown to increase the
risk of stroke. Although continuous positive airway pressure (CPAP) is considered the …

Purpose The associations between obstructive sleep apnea (OSA) and all-cause and
cardiovascular mortality are well established but are not entirely consistent. To accurately …

Background Obstructive sleep apnea is associated with an increased risk of cardiovascular
events; whether treatment with continuous positive airway pressure (CPAP) prevents major …

Obstructive sleep apnea (OSA) is associated with increased cardiovascular morbidity and
mortality. Continuous positive airway pressure (CPAP) is the main treatment of OSA. The …

Obstructive sleep apnea (OSA), prevalent in patients with stroke, increases the risks of
cardiovascular events and stroke. This meta-analysis evaluated the effectiveness of …

Background Obstructive sleep apnea (OSA) is highly prevalent in patients with coronary
artery disease (CAD) and is associated with recurrent cardiovascular risk. However, whether …